Cargando…

Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses

INTRODUCTION: Rapid improvement of psoriasis is valued by patients and should be considered to be an important factor in treatment selection. We investigated Psoriasis Area and Severity Index (PASI) and Dermatology Life Quality Index (DLQI) response rates within the first 12 weeks of treatment to co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warren, Richard B., See, Kyoungah, Burge, Russel, Zhang, Ying, Brnabic, Alan, Gallo, Gaia, Garrelts, Alyssa, Egeberg, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994587/ https://www.ncbi.nlm.nih.gov/pubmed/31686337 http://dx.doi.org/10.1007/s13555-019-00337-y

Ejemplares similares

Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort
por: Egeberg, Alexander, et al.
Publicado: (2020)

Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis
por: Leonardi, Craig L., et al.
Publicado: (2022)

Psoriasis Severity Assessment Combining Physician and Patient Reported Outcomes: The Optimal Psoriasis Assessment Tool
por: Leonardi, Craig, et al.
Publicado: (2021)

Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-Analysis
por: Blauvelt, Andrew, et al.
Publicado: (2022)

Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis: a systematic review
por: Blauvelt, Andrew, et al.
Publicado: (2021)

Introduction to Frequentist and Bayesian Fitting
por: James, F
Publicado: (2007)

Bayesian and frequentist regression methods
por: Wakefield, Jon
Publicado: (2013)

Bayesian versus frequentist upper limits
por: Rover, Christian, et al.
Publicado: (2011)

Frequentist and Bayesian Quantum Phase Estimation
por: Li, Yan, et al.
Publicado: (2018)

Dynamic Visual Representation of Clinical Efficacy of Ixekizumab in Psoriasis
por: Hawkes, Jason E., et al.
Publicado: (2021)

Bayesian-frequentist hybrid inference framework for single cell RNA-seq analyses
por: Han, Gang, et al.
Publicado: (2023)

Brain dopamine receptor system is not altered in obesity: Bayesian and frequentist meta‐analyses
por: Pak, Kyoungjune, et al.
Publicado: (2023)

Treatment Persistence of Ixekizumab in Adults with Moderate-to-Severe Plaque Psoriasis Participating in the Canadian Patient Support Program
por: Gulliver, Wayne, et al.
Publicado: (2022)

A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
por: Kirkham, Bruce W., et al.
Publicado: (2023)

A comparison of the Bayesian and frequentist approaches to estimation
por: Samaniego, Francisco J
Publicado: (2010)

Frequentist versus Bayesian approaches to multiple testing
por: Sjölander, Arvid, et al.
Publicado: (2019)

Frequentist against Bayesian statistics: tug of war!
por: Nair, Abhijit
Publicado: (2022)

Frequentist analyses of solar neutrino data
por: Creminelli, Paolo, et al.
Publicado: (2001)

Bayesians versus frequentists: a philosophical debate on statistical reasoning
por: Vallverdú, Jordi
Publicado: (2016)

Comparison of Bayesian and frequentist methods for prevalence estimation under misclassification
por: Flor, Matthias, et al.
Publicado: (2020)

Comparison of Bayesian and frequentist group-sequential clinical trial designs
por: Stallard, Nigel, et al.
Publicado: (2020)

Interpreting frequentist hypothesis tests: insights from Bayesian inference
por: Sidebotham, David, et al.
Publicado: (2023)

Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial
por: Paller, Amy S., et al.
Publicado: (2022)

Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes
por: Egeberg, Alexander, et al.
Publicado: (2023)

Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
por: Elewski, Boni E., et al.
Publicado: (2022)

Understanding Treatment Preferences in Patients with Moderate to Severe Plaque Psoriasis in the USA: Results from a Cross-Sectional Patient Survey
por: Gorelick, Joe, et al.
Publicado: (2019)

Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes
por: Egeberg, Alexander, et al.
Publicado: (2023)

Contemporary Bayesian and Frequentist Statistical Research Methods for Natural Resource Scientists
por: Stauffer, Howard B
Publicado: (2007)

Measuring and Controlling Bias for Some Bayesian Inferences and the Relation to Frequentist Criteria
por: Evans, Michael, et al.
Publicado: (2021)

Frequentist and Bayesian analysis of potential adverse events of the COVID-19 immunization
por: Davis, M., et al.
Publicado: (2023)

Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate‐to‐severe genital psoriasis
por: Merola, J.F., et al.
Publicado: (2020)

Carbon dioxide effects on daytime sleepiness and EEG signal: A combinational approach using classical frequentist and Bayesian analyses
por: Jin, Rui Nian, et al.
Publicado: (2022)

A comparison of frequentist and Bayesian approaches to the estimation of long-stay per-diems
por: Hatcher, Jeff, et al.
Publicado: (2009)

Statistical matching: a frequentist theory, practical applications, and alternative bayesian approaches
por: Rässler, Susanne
Publicado: (2002)

Frequentist and Bayesian Regression Approaches for Determining Risk Factors of Child Mortality in Ghana
por: Iddrisu, Abdul-Karim, et al.
Publicado: (2020)

Evaluating the performance of Bayesian and frequentist approaches for longitudinal modeling: application to Alzheimer’s disease
por: Pérez-Millan, Agnès, et al.
Publicado: (2022)

Statistical Significance Testing for Mixed Priors: A Combined Bayesian and Frequentist Analysis
por: Robnik, Jakob, et al.
Publicado: (2022)

Indirect Comparison of Lanadelumab and Intravenous C1-INH Using Data from the HELP and CHANGE Studies: Bayesian and Frequentist Analyses
por: Mendivil, Joan, et al.
Publicado: (2021)

A Retrospective Cohort Analysis of Treatment Patterns Over 1 Year in Patients with Psoriasis Treated with Ixekizumab or Guselkumab
por: Blauvelt, Andrew, et al.
Publicado: (2022)

Frequentist and Bayesian approaches for food allergen risk assessment: risk outcome and uncertainty comparisons
por: Birot, Sophie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cm76dd74hnd9cg396njkqrl1i5